By: Editorial Staff, Date: March 7th, 2023
2023 is likely to be a pivotal year for psychedelic therapy as it starts to gain mainstream acceptance in the medical industry. Let’s track the legalization of psychedelics in the U.S.
Join our webcast: The Highs and Lows of Psychedelic Therapy: Navigating Legal Complexities
Significant FDA Enforcement Developments: Challenges and Opportunities
In 2022, new legislation, evolving regulations and policies, supply chain disruptions, and public health crises dominated the FDA regulatory landscape. In 2023, FDA is expected to continue to implement its new legislative authorities, advance its regulation of cutting-edge issues, address significant supply chain concerns, and deal with the fallout from the COVID-19 public health emergency.